CLN3 and breast cancer: One form of LF is secreted in body fluids (sLF) whereas an alternative form deltal LF, regulated by a different promoter, is present in normal tissues. Delta LF is downregulated in breast cancer. The CLN3 promoter is downregulated in delta LF expressing HEK cell upon heat shock in microarray experiments.